Cancer encompasses over 100 distinct types, each originating in different tissues and cells. Commonly known cancers include carcinoma, which arises in epithelial cells, and sarcoma, originating in bone, muscle, or connective tissues. Leukemia targets blood-forming tissues, disrupting normal blood cell production, while lymphoma and myeloma impact the immune system by affecting lymph nodes and plasma cells, respectively.
Recent advancements in cancer research are shedding light on rarer types, like neuroendocrine tumors and pediatric-specific cancers. Scientists are exploring molecular and genetic factors that distinguish each type, fostering breakthroughs in personalized medicine. This research is critical for developing targeted therapies that improve survival rates and quality of life for diverse cancer populations.
Title : RNA binding proteins in the pathogenesis of pediatric cancer
Atif A Ahmed, University of Washington-Seattle Children’s Hospital, United States
Title : A novel mRNA genomic technology for precision medicine, early cancer diagnosis, prognosis, treatment follow-up and cancer gene therapy
Rajvir Dahiya, University of California San Francisco, United States
Title :
Jianhua Luo, University of Pittsburgh, United States
Title : Biosensor-based detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Principles of oral rehabilitation in H&N cancer patients
Pietro Salvatori, Independent H&N Surgeon, Italy
Title :
Marika Crohns, Impactful Innovations Management Consultants LLC, United Arab Emirates